Breast cancer chemotherapy is a whole-system treatment.
An inventory of knowledge about breast cancer chemotherapy:
Introduction
Breast cancer is one of the most common cancers in the world, especially among women. The early detection and treatment of breast cancer has yielded significant results as medical technology continues to improve. As an important component of breast cancer treatment, chemotherapy often confuses and worries patients. This paper will provide an in-depth review of the knowledge of breast cancer chemotherapy, including its mechanisms of functioning, adaptability, common drugs, treatment programmes, common side effects and responses to help patients and their families better understand and respond to the chemotherapy process.
Overview of breast cancer
Breast cancer is a malignant tumour derived from breast tissues, and the most common types include immersion catheter cancer, immersion leaf cancer, special types of cancer, etc. The occurrence of breast cancer is related to a number of factors, in addition to genetic factors, and hormonal levels, lifestyles, environmental factors, etc. may affect the risk of morbidity. The key to early detection of breast cancer is regular mammography, video screening (e.g. mammography X-ray, ultrasound, etc.). If breast cancer is diagnosed, it should be actively treated as soon as possible. Treatment programmes usually include surgery, treatment, chemotherapy, endocrinology treatment and target-oriented treatment, depending on the age of the patient, the tumour period and the molecular type.
The role of chemotherapy
chemotherapy refers to the use of drugs to kill rapidly growing cancer cells. The main objectives of breast cancer chemotherapy are:
1. Reduction of tumours: In some cases, chemotherapy can be used before the operation to reduce the size of the tumour and to increase the chances of surgery (newly assisted chemotherapy).
2. Elimination of micro-residuals: Post-operative chemotherapy can reduce the incidence of re-emergence of cancer (auxiliary chemotherapy).
3. Extension of life: chemotherapy can control the progress of tumours and extend the life of patients.
4. Symptoms: For some terminally incurable patients, chemotherapy can help to relieve symptoms, prolong survival and improve the quality of life.
Chemotherapy adaptation.
Not all breast cancer patients are in need of chemotherapy, which includes, inter alia:
1. Local late breast cancer: chemotherapy is usually provided for breast cancer patients with relatively large primary tumours or with regional lymphoma transfer.
Early breast cancer: Some high-risk early breast cancer patients (e.g. Her2-positive, triple-negative breast cancer) may require complementary chemotherapy.
3. Re-emergence or transfer of breast cancer: chemotherapy is often one of the main treatments for breast cancer patients who have experienced re-emergence or long-distance transfer.
Common chemotherapy
There is a wide variety of chemotherapy drugs for breast cancer, and common chemotherapy drugs include:
Platinum-type drugs: The combination of platinum and carpenter, with other drugs, can enhance the efficacy of the treatment, especially for patients with a BRCA genetic mutation associated with triple-negative breast cancer.
2. Vishuol, e.g. Vishuol and Dosefol, which effectively inhibit the growth of cancer cells, is one of the most commonly used drugs for breast cancer chemotherapy.
3. The cystals, such as acin, spectroacin and lipids, are highly active and resistant to cancer, but they have some heart toxicity and are generally not recommended for application with anti-HER2-targeting drugs.
Fluorine-type drugs: e.g., fluorine, have good therapeutic effects on certain types of breast cancer.
These drugs are often used in combination or in combination with targeted drugs, and individualized treatment programmes are developed based on the molecular stratification of different patients.
Common side effects and response measures
While chemotherapy can be effective against cancer, it is accompanied by some side effects, which vary from individual to individual, and common side effects include:
1. Disgusting and vomiting: It can be mitigated by the preventive use of anti-pussing drugs, and for programmes with high risk of vomiting, it can be mitigated by three combinations.
2. Demobilization: chemotherapy can lead to different degrees of demobilization of patients, generally of a temporary nature and usually recovery after treatment has ended.
Osteo marrow inhibition: e.g. reduction of leukemia (vulnerable), reduction of erythrocytes (aemia), reduction of slabs (e.g. haemorrhage). Regular blood testing is necessary to adapt treatment programmes to the situation and, if necessary, to use preventive white therapy.
4. Incapacity: Many patients are extremely tired during chemotherapy and recommend appropriate rest and light exercise.
5. Oral ulcer: oral mucusitis resulting from chemotherapy can be prevented and treated through the maintenance of oral hygiene and the use of antibacterial mouthwash.
Concubine or diarrhea: maintain good eating habits and, if necessary, regulate with drugs.
Summary
The chemotherapy of breast cancer is a complex and individualized process, and patients need to maintain a positive mindset and good communication with doctors during chemotherapy. At the same time, knowledge of chemotherapy can help patients and their families to meet the challenges of this treatment. For breast cancer patients, the combination of scientifically sound treatment programmes and a good lifestyle will help to improve survival and quality of life. Whatever the difficulties, patients should be convinced that the progressive development of modern medicine offers new hope for the treatment of breast cancer. Through early detection, rationalization and active recovery, many breast cancer patients have achieved their long-term survival and health aspirations.
Breast cancer
